2 lawmakers push for Avandia to be withdrawn from the market

06/28/2010 | Hill, The

A joint statement from Sen. Chuck Grassley, R-Iowa, and Rep. Rosa DeLauro, D-Conn., calls on the FDA to withdraw GlaxoSmithKline's Avandia from the market, after two studies confirmed that the drug poses serious risks in diabetics. The first study showed that Avandia increases patients' risk of heart attack, while the second study found that the drug raises the risk for stroke, heart failure and death.

View Full Article in:

Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID